Experienced growth-stage investor and operator with sector focus on software and fintech. Kyle Jones brings a background in product leadership and venture investing, advising portfolio companies on go-to-market, unit economics and scaling customer acquisition. Prior roles include operating leadership at late-stage startups and investment work at a venture firm; holds an MBA and engineering undergrad. Active on early growth and Series A allocations.
Experienced growth-stage investor and operator with sector focus on software and fintech. Kyle Jones brings a background in product leadership and venture investing, advising portfolio companies on go-to-market, unit economics and scaling customer acquisition. Prior roles include operating leadership at late-stage startups and investment work at a venture firm; holds an MBA and engineering undergrad. Active on early growth and Series A allocations.
Targets growth-stage software and fintech businesses, favoring Series A and early growth rounds where product-led scaling meets repeatable unit economics. Investment style combines operator lens with venture discipline: prioritize founders with defensible product differentiation, data-driven go-to-market plans, and clear customer economics. Capital allocated to accelerate customer acquisition and measurable CAC payback, with active board/advisory involvement to shape product roadmap, metrics and scalable sales motions over a 3–7 year return horizon.
Targets growth-stage software and fintech businesses, favoring Series A and early growth rounds where product-led scaling meets repeatable unit economics. Investment style combines operator lens with venture discipline: prioritize founders with defensible product differentiation, data-driven go-to-market plans, and clear customer economics. Capital allocated to accelerate customer acquisition and measurable CAC payback, with active board/advisory involvement to shape product roadmap, metrics and scalable sales motions over a 3–7 year return horizon.
| Trades 3304 | Longs Won 2162/3304 65% | Profit Factor 6.97 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $234,161.69 |
| Average Win $31,299.2 | Best Trade (Aug 14) $6.54M | Sharpe Ratio -14.29 |
| Average Loss -$8,495.93 | Worst Trade (Jun 30) -$1.97M | Z-Score 1.23 (78.09%) |
| Commissions $0 | Avg. Trade Length 1y 6d | Expectancy $17,544.35 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 43,478 | 39,130 | 34,783 | 30,435 | 26,087 | 21,739 | 17,391 | 13,043 | 8,696 | 4,348 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 26 | $3,614.76 | $3,597.62 | - | -$17.14 | -0.47% | -0.245% |
AAL American Airlines Group Inc. | 61 | $838 | $931.47 | - | $93.47 | 11.15% | -1.037% |
AAPL Apple Inc. | 1,819 | $439,296.74 | $561,907.29 | - | $122,610.55 | 27.91% | -7.354% |
ABBV AbbVie Inc. | 485 | $80,335.46 | $121,705.9 | - | $41,370.44 | 51.5% | -2.513% |
ABNB Airbnb, Inc. | 2 | $253.6 | $303.04 | - | $49.44 | 19.5% | -0.368% |
ABT Abbott Laboratories | 337 | $39,908.83 | $35,620.9 | - | -$4,287.93 | -10.74% | +0.085% |
ACGL Arch Capital Group Ltd | 27 | $2,552.93 | $2,714.31 | - | $161.38 | 6.32% | -0.603% |
ACN Accenture plc Class A | 24 | $7,808.01 | $3,982.08 | - | -$3,825.93 | -49% | +1.611% |
ACWV iShares MSCI Global Minimum Volatility ETF | 277 | $27,873.1 | $34,480.96 | - | $6,607.86 | 23.71% | -0.328% |
ADAM Adamas Trust, Inc. | 143 | $1,183.45 | $1,297.01 | - | $113.56 | 9.6% | +1.454% |
ADI Analog Devices, Inc. | 51 | $10,808.71 | $18,737.91 | - | $7,929.2 | 73.36% | +0.202% |
ADM Archer-Daniels-Midland Co | 52 | $2,630.52 | $4,122.04 | - | $1,491.52 | 56.7% | -1.662% |
ADP Automatic Data Processing Inc. | 18 | $4,347.43 | $4,796.28 | - | $448.85 | 10.32% | +0.982% |
AEE Ameren Corporation | 3,249 | $297,485.15 | $356,122.89 | - | $58,637.74 | 19.71% | +0.791% |
AFL Aflac Inc. | 1,148 | $95,371.8 | $146,347.04 | - | $50,975.24 | 53.45% | +0.094% |
AGG iShares Core U.S. Aggregate Bond ETF | 49 | $4,950.87 | $4,771.13 | - | -$179.74 | -3.63% | -0.256% |
AGNT eXp World Holdings Inc. | 1,098 | $16,896.87 | $4,446.9 | - | -$12,449.97 | -73.68% | +3.846% |
AJG Arthur J. Gallagher & Co. | 25 | $6,251 | $6,235.5 | - | -$15.5 | -0.25% | -2.745% |
ALDX Aldeyra Therapeutics Inc. | 600 | $3,132 | $924 | - | -$2,208 | -70.5% | -3.75% |
ALGN Align Technology, Inc. | 21 | $3,076.29 | $3,552.36 | - | $476.07 | 15.48% | -2.451% |